Guanghui Cui
No.1 East Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
PKN2 enhances the immunosuppressive activity of polymorphonuclear myeloid-derived suppressor cells in esophageal carcinoma by mediating fatty acid oxidation.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 18, 2024
Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Journal: Disease markers
Published: September 29, 2022
Intermittent hypoxia-induced downregulation of microRNA-320b promotes lung cancer tumorigenesis by increasing CDT1 via USP37.
Journal: Molecular therapy. Nucleic acids
Published: April 28, 2020
Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR-PI3K-AKT-mTOR signalling pathway.
Journal: Journal of cellular and molecular medicine
Published: June 24, 2019
PPARGC1A is upregulated and facilitates lung cancer metastasis.
Journal: Experimental cell research
Published: July 11, 2017
Genetic variation of lncRNA GAS5 contributes to the development of lung cancer.
Journal: Oncotarget
Published: May 18, 2017
A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer.
Journal: Medicine
Published: April 07, 2017
Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Journal: Oncology reports
Published: November 25, 2016
Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: March 17, 2016
Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells.
Journal: Medical oncology (Northwood, London, England)
Published: March 09, 2015
MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: May 06, 2014
Last Updated: 09/26/2026